Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does aprotinin increase the long-term risk of mortality in patients undergoing CABG surgery?

Nature Clinical Practice Cardiovascular Medicine volume 4, pages 416–417 (2007)Cite this article

boxed-textMangano DT et al. for the Investigators of The Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation (2007) Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 297: 471–479

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Royston D et al. (1987) Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 2: 1289–1291

    Article  CAS  Google Scholar 

  2. Sedrakyan A et al. (2004) Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 128: 442–448

    Article  CAS  Google Scholar 

  3. Mangano DT et al. for the Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation (2006) The risk associated with aprotinin in cardiac surgery. N Engl J Med 354: 353–365

    Article  CAS  Google Scholar 

  4. Ferguson TB Jr (2007) Aprotinin—are there lessons learned? JAMA 297: 527–529

    Article  CAS  Google Scholar 

  5. Engoren MC et al. (2002) Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 74: 1180–1186

    Article  Google Scholar 

  6. Landis RC et al. (2001) The antithrombotic and anti-inflammatory mechanisms of action of aprotinin. Ann Thorac Surg 72: 2169–2175

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. British Heart Foundation Department of Cardiac Surgery, National Heart and Lung Institute, Imperial College, Hammersmith Hospital, B Block, Second Floor, Du Cane Road, London W12 0HS, UK k.m.taylor@ic.ac.uk

Authors and Affiliations

  1. K Taylor holds the British Heart Foundation Chair in Cardiac Surgery at the University of London and Imperial College, and is Director of Cardiac Services at the Hammersmith Hospital, London, UK.,

    Ken Taylor

Authors
  1. Ken Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author has received honoraria for lectures from Bayer AG.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taylor, K. Does aprotinin increase the long-term risk of mortality in patients undergoing CABG surgery?. Nat Rev Cardiol 4, 416–417 (2007). https://doi.org/10.1038/ncpcardio0934

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0934

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing